KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Amortization - Intangibles (2016)

Teva Pharmaceutical Industries filings provide 5 years of Amortization - Intangibles readings, the most recent being $170.0 million for Q4 2016.

  • On a quarterly basis, Amortization - Intangibles fell 12.37% to $170.0 million in Q4 2016 year-over-year; TTM through Dec 2016 was $876.0 million, a 10.15% decrease, with the full-year FY2016 number at $170.0 million, down 78.96% from a year prior.
  • Amortization - Intangibles hit $170.0 million in Q4 2016 for Teva Pharmaceutical Industries, down from $194.0 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $269.0 million in Q1 2013 to a low of $170.0 million in Q4 2016.
  • Median Amortization - Intangibles over the past 4 years was $244.0 million (2014), compared with a mean of $229.0 million.
  • Biggest five-year swings in Amortization - Intangibles: dropped 0.37% in 2014 and later fell 20.49% in 2015.
  • Teva Pharmaceutical Industries' Amortization - Intangibles stood at $269.0 million in 2013, then decreased by 9.29% to $244.0 million in 2014, then fell by 20.49% to $194.0 million in 2015, then decreased by 12.37% to $170.0 million in 2016.
  • The last three reported values for Amortization - Intangibles were $170.0 million (Q4 2016), $194.0 million (Q4 2015), and $244.0 million (Q4 2014) per Business Quant data.